About Dharmacon
Dharmacon is a company based in Lafayette (United States) founded in 1995 was acquired by Horizon Discovery in July 2017.. Dharmacon has raised $5.7 million across 1 funding round from investors including Horizon Discovery, Boulder Ventures and Telegraph Hill Partners. Dharmacon offers products and services including CRISPR Guide RNA, siRNA, Custom Oligonucleotides, and Transfection Reagents. Dharmacon operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Lafayette, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Revvity Discovery Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.7 M (USD)
in 1 rounds
-
Latest Funding Round
$5.7 M (USD), Series A
Aug 23, 2002
-
Investors
Horizon Discovery
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Horizon Discovery
(Jul 19, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dharmacon
Dharmacon offers a comprehensive portfolio of products and services, including CRISPR Guide RNA, siRNA, Custom Oligonucleotides, and Transfection Reagents. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Reagents for precise genome modification in research.
Tools for RNA interference to silence gene expression.
Tailored RNA and DNA for specific research applications.
Products to deliver nucleic acids into cells efficiently.
Funding Insights of Dharmacon
Dharmacon has successfully raised a total of $5.7M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.7 million completed in August 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $5.7M
-
First Round
First Round
(23 Aug 2002)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2002 | Amount | Series A - Dharmacon | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Dharmacon
Dharmacon has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Horizon Discovery, Boulder Ventures and Telegraph Hill Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is offered by Boulder Ventures for innovative companies.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
Genetically modified cell lines are developed using AAV gene-editing platform.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dharmacon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Dharmacon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dharmacon Comparisons
Competitors of Dharmacon
Dharmacon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Dharmacon
When was Dharmacon founded?
Dharmacon was founded in 1995 and raised its 1st funding round 7 years after it was founded.
Where is Dharmacon located?
Dharmacon is headquartered in Lafayette, United States. It is registered at Lafayette, Louisiana, United States.
Is Dharmacon a funded company?
Dharmacon is a funded company, having raised a total of $5.7M across 1 funding round to date. The company's 1st funding round was a Series A of $5.7M, raised on Aug 23, 2002.
What does Dharmacon do?
Dharmacon was founded in 1995 in Lafayette, United States, and operates within the biotechnology sector. Technology for RNA oligonucleotide synthesis is offered, including the 2-ACE RNA method for high-quality synthetic RNA. RNAi-related products and siRNA design services are provided, along with CRISPR Cas9 gene editing tools, custom RNA synthesis, and functional genomic screening capabilities to support various research needs.
Who are the top competitors of Dharmacon?
Dharmacon's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Dharmacon offer?
Dharmacon offers CRISPR Guide RNA, siRNA, Custom Oligonucleotides, and Transfection Reagents.
Who are Dharmacon's investors?
Dharmacon has 3 investors. Key investors include Horizon Discovery, Boulder Ventures, and Telegraph Hill Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.